BGLAP and rheumatoid arthritis: A recent study found that RA patients who had a high bone turnover levels measured as the ratio between serum CTX-I and osteocalcin and who simultaneously had low serum C2M levels, indicating slow cartilage degradation, were more likely to respond to anti-IL-6R treatment [144].